A Phase 1 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical Trial ID NCT01375842

PubWeight™ 77.14^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01375842

Top papers